PubMed · 2016 · 19 citations · 3 references
Life SciencesBiochemistryMolecular BiologyApoptosisEnzymologyInflammationPancreatic DiseasesPancreatic DisordersPancreatic PathologyBortezomib TherapyBortezomib-based TherapyPancreatic InjuryProteasome DysfunctionProteasome Inhibitor TherapyProteasome InhibitorsProteasome System
No abstract available. Image: Illustration of the proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16). (Author: Opabinia regalis; Wikimedia Commons)
3
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text